Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

PSCDD

Financiado

Cerrado

Protein Specific Charges for Drug Discovery

Optimisation of the inhibitory potency of a drug candidate requires an accurate description of the interactions between the compound and its target protein receptor. State-of-the-art computational simulations of drug potency rely... ver más

30/06/2016

THE CHANCELLOR MAS...

283K€

Presupuesto del proyecto: 283K€

Líder del proyecto

THE CHANCELLOR MASTERS AND SCHOLARS OF THE UN... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2016-06-30 No tenemos la información de la convocatoria

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

THE CHANCELLOR MASTERS AND S...

0.00€ | Lider

Proyectos interesantes

RTI2018-101032-J-I00

Medical Technol...

Data Science

154K€ Cerrado

UNAH13-4E-2006

Medical Technol...

Data Science

20K€ Cerrado

BES-2011-047629

Medical Technol...

Data Science

43K€ Cerrado

FRAGMENT2DRUG

Medical Technol...

Data Science

1M€ Cerrado

SAF2012-39760-C02-01

Medical Technol...

Data Science

328K€ Cerrado

PELE

Medical Technol...

Data Science

1M€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Líder del proyecto

THE CHANCELLOR MASTERS AND SCHOLARS OF THE UN... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 283K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Optimisation of the inhibitory potency of a drug candidate requires an accurate description of the interactions between the compound and its target protein receptor. State-of-the-art computational simulations of drug potency rely on classical molecular mechanics force fields with atom-centred point charges, which are often fit to reproduce quantum mechanical properties of small molecules. Yet recent advances in linear-scaling density functional theory software allow quantum mechanical simulations of biomolecules comprising thousands of atoms. A method is described to enhance the accuracy of computational predictions of drug binding by deriving the point charges of the target receptor directly from a single quantum mechanical simulation of the entire protein, thus incorporating the electrostatic polarisation of the protein's native state into the charge fitting procedure. The method will be validated against experimentally measured benchmark potencies of p38 MAP kinase inhibitors and applied in a prospective search for novel pharmaceutical compounds that disrupt interactions of the von Hippel-Lindau protein, which is being investigated as a target for treatment of chronic anaemia associated with kidney disease and cancer chemotherapy. Promising compounds will be synthesised and assayed for potency by the outgoing host. The mobility phase of the project enhances the synergy between computation and experiment, thus increasing confidence in the developed methods and the likelihood of widespread uptake by the pharmaceutical community. As well as broadening the EU's portfolio in basic pharmaceutical research, the project is structured to train the applicant in drug design and enhance his network of international and inter-disciplinary collaborators, thus improving his prospects of establishing an independent research career at the boundary between electronic structure theory and the Life Sciences on returning to the European Research Area.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores